Studies have reported that increased expression of EGFR family proteins are a poor prognostic factor for cancer patients (30–32); is also associated with tumor aggressiveness (32) and resistance to chemotherapy (30) and their levels are increased in 30% of solid tumors (31). This evidence concerns the gene EGFR and neoplasm.